# K093526: V.a.C. Via Therapy System, V.a.C. Via Negative Pressure Therapy Unit, V.a.C. Via Dressing (Containing V.a.C. Granufoam D

- Pathway: 510(k) (Traditional)
- Applicant: Kci USA, Inc. (Kinetic Concepts, Inc.)
- Decided: Mar 10, 2010 after 114 days
- Product code: OMP (Negative Pressure Wound Therapy Powered Suction Pump)
- Device class: 2
- Regulation: 21 CFR 878.4780
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 4 generations back to K945062 (1995). 6 ancestors in all.
17 later devices descend from it; 2 cite it directly.
0 of 24 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K063692: V.a.C. Therapy Systems-Acti V.a.C. Therapy Unit Model# 340000, Kci USA, Inc. (2007) Summary page 1.
- K091585: Vac Therapy System, Models 340000, M8259999, 320000, M8259968 and 320100, Kci USA, Inc. (2009). Cleared while this submission was under review Summary page 1.

## Most influential descendants
- K113678: Invia Motion Negative Pressure Wound Therapy System (2012), 11 descendants of its own
- K170088: Invia Foam Dressing Kits with FitPad, Invia Foam Dressing Kits with FitPad, Invia Gauze Dressing Kits with FitPad, Invia FitPad, Invia Transparent Film (2017), 8 descendants of its own
- K141926: Invia Endure Negative Pressure Wound Therapy System (2014), 5 descendants of its own
- K161128: Invia Motion-Endure Negative Pressure Wound Therapy System, Invia Motion-7-120 Days Negative Pressure Wound Therapy System, Invia Motion Canister/Tubing Set 0.151, Invia Motion Carrying Case, Power Supply (2016), 4 descendants of its own
- K132741: V.a.C. Via Negative Pressure Wound Therapy System (2013), 4 descendants of its own

## Indications for use
The V.A.C.Via Tm Negative Pressure Wound Therapy System is an integrated wound management system for use in acute, extended and home care settings. It is intended to create an environment that promotes wound healing by secondary or tertiary (delayed primary) intention by preparing the wound bed for closure, reducing edema, promoting granulation tissue formation and perfusion, and by removing exudates and infectious material. It is indicated for patients with chronic, acute, traumatic, subacute and dehisced wounds, partial-thickness burns, ulcers (such as diabetic, pressure or venous insufficiency), flaps and grafts

Source page: https://510kreport.com/device/K093526
Methodology: https://510kreport.com/methodology